Oleon NV
USPTO PatentsView assignee record - 12 granted patents across 15 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07C (Acyclic OR Carbocyclic Compounds).
The verdict
According to USPTO PatentsView, Oleon ranks #23,125 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 15 technology areas.
- #23,125
- of 49,997 US assignees by volume
- Top 32%
- by Innovation Score (41.8/100)
- 13.6
- avg claims per patent
- +167%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R23125 · Foreign Corporation #23,125 · 12 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 12 grants
- MID-PACK #23,125/49,997
- PHOTO-FINISH Nxera Pharma UK
- CPC-FOCUS C07C · 15 areas
- INNOV-PAR 41.8/100
- CLAIMS-RICH 13.6 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +167% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Nxera Pharma UK Limited (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Oleon’s 41.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Oleon
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Oleon · this assignee
Oleon · this assignee
42 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Oleon's Innovation Score is 41.8/100 (top 32% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Oleon?
Each dot is one of Oleon’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Oleon’s own 13.6 claims/patent is ABOVE the 9.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Oleon's grants concentrate
Oleon NV is a focused PatentsView assignee: 15 CPC subclasses with 33.3% of grants classified under C07C (Acyclic OR Carbocyclic Compounds). Peak complete grant year is 2021 (3 grants) versus a trough of 1 in 2018. By volume, Oleon sits between Nxera Pharma UK Limited and Ooni Limited.
Oleon's three-year grant acceleration
Oleon NV shows 5 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Oleon's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Nxera Pharma UK
Nxera Pharma UK Limited
12 patents
- Obschestvo S Ogra…
Obschestvo S Ogranichennoi Otvetstvennostyu “WELDUP”
12 patents
- OCM
OCM Inc.
12 patents
- Officine Maccafer…
Officine Maccaferri S.P.A.
12 patents
- Omnimax Internati…
Omnimax International, LLC
12 patents
- ONE Concern
ONE Concern, Inc.
12 patents
- Onesteel Wire PTY
Onesteel Wire PTY Limited
12 patents
- Ooni
Ooni Limited
12 patents
- Oleon ◀
Oleon NV
12 patents
What this shows Oleon holds 12 patents at rank #23,113, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Oleon
By rank, the assignees closest to #23,113 in granted patent volume.
- Nxera Pharma UK Limited #23,109 · 12 patents
- Obschestvo S Ogranichennoi Otvetstvennostyu “WELDUP” #23,110 · 12 patents
- OCM Inc. #23,111 · 12 patents
- Officine Maccaferri S.P.A. #23,112 · 12 patents
- Omnimax International, LLC #23,114 · 12 patents
- ONE Concern, Inc. #23,115 · 12 patents
- Onesteel Wire PTY Limited #23,116 · 12 patents
- Ooni Limited #23,117 · 12 patents
Leaders in C07C (Acyclic OR Carbocyclic Compounds)
Other assignees with the most granted patents in Oleon's primary technology class.
Oleon's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
42 Top 32% higher than 68% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 16.7% |
| 2018 | 1 | 8.3% |
| 2021 | 3 | 25.0% |
| 2022 | 2 | 16.7% |
| 2024 | 3 | 25.0% |
| 2025partial year | 1 | 8.3% |
Which technologies does Oleon NV patent most?
Top 15 of 15 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Oleon NV's patent record in context - here's where to go next.
- Oleon NV's lead technology class is C07C (Acyclic OR Carbocyclic Compounds), 33.3% of its portfolio - see every assignee active in that class. Explore C07C
- Ranked #23,125 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Oleon NV against Nxera Pharma UK Limited, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 41.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.